Bone markers in the management of metastatic bone disease.

Abstract

Newer markers of bone formation and bone resorption are now available. Alone these new markers do not appear to be useful to diagnose metastatic bone disease. Several markers appear to be of prognostic importance and correlate with the extent of tumour in the skeleton. Serial monitoring of bone markers may be useful to monitor the efficacy of bisphosphonate and/or systemic therapy of both lytic and blastic bone metastases.

050100150'04'06'08'10'12'14'16
Citations per Year

629 Citations

Semantic Scholar estimates that this publication has 629 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Lipton2001BoneMI, title={Bone markers in the management of metastatic bone disease.}, author={Allan Lipton and L{\'u}cia Costa and Suhail Ali and Laurence M. Demers}, journal={Cancer treatment reviews}, year={2001}, volume={27 3}, pages={181-5} }